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The introduction of the CTLA-4 recombinant fusion protein has demonstrated therapeutic
effects by selectively modulating T-cell activation in rheumatoid arthritis. Here we show,
using a forward genetic approach, that a mutation in the SH3gl1 gene encoding the endocytic
protein Endophilin A2 is associated with the development of arthritis in rodents. Defective
expression of SH3gl1 affects T cell effector functions and alters the activation threshold of
autoreactive T cells, thereby leading to complete protection from chronic autoimmune
inflammatory disease in both mice and rats. We further show that SH3GL1 regulates human T
cell signaling and T cell receptor internalization, and its expression is upregulated in rheu-
matoid arthritis patients. Collectively our data identify SH3GL1 as a key regulator of T cell
activation, and as a potential target for treatment of autoimmune diseases.
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Aberrant activation of autoreactive T cells has been sug-gested to initiate and drive autoimmune diseases, such asrheumatoid arthritis (RA) and multiple sclerosis (MS). It
is believed that RA is initiated years before the clinical onset
through an activation of major histocompatibility complex
(MHC) class II-restricted autoreactive T cells that give specific
help to B cells, leading to production of autoantibodies1. In RA,
the chronic inflammatory attack of the joints, initiated by the
adaptive immune system, is followed by an increased production
of inflammatory cytokines such as TNF and IL-6 and during the
last decades effective pharmaceutical treatments neutralizing this
late inflammatory phase have been developed. Although early
treatment has been shown to be more effective, as it improves the
possibility to interfere with the underlying cause of autoimmune
diseases, patients receive treatment well after disease is estab-
lished2. Thus, a better understanding of the role of the adaptive
immune system that drives the early stages of the disease i.e.
before the disease is clinically overt, is needed to improve treat-
ment of autoimmune diseases.
Genetic predisposition of RA is known to be strongly asso-
ciated with MHC class II genes implicating a major contribution
of T cells. Additionally, a recent genome wide meta-analysis
revealed over 100 non-MHC risk loci where many were suggested
to be related to T cell immune functions3. T cells can be found in
abundance in the synovium of RA patients4 and the successful
use of T cell targeting therapy, such as the CTLA-4-Ig fusion
antibody abatacept, confirm the importance of T cells in the
chronic stage of the disease. These observations are corroborated
in animal models for RA, where depletion of T cells by use of
antibodies or gene deletion protects against disease induction5,6.
A specific role of the T cell receptor (TCR) in regulating devel-
opment of arthritis has been further illustrated in the SKG
mouse7, where a mutation in TCR signaling molecule Zap70 leads
to altered TCR signaling. This in turn skews T cell development
in the thymus increasing the number of autoreactive T cells
leading to subsequent development of arthritis.
Herein, we have identified Endophilin A2 (EA2), encoded by
the SH3gl1 gene, as a regulator of TCR internalization, signaling
and downstream T cell effector functions. So far, EA2 has pre-
dominantly been studied in synaptic transmission in the central
nervous system and in cancer8–10. We demonstrate that deficient
expression of SH3gl1, caused by either a spontaneous mutation in
the DA rat, or in genetically modified mice, leads to protection
against autoimmunity. We hereby report that EA2 has a funda-
mental role in autoimmunity and limits the induction of auto-
reactive T cells. The discovery of the EA2’s impact on T cell
activation opens up to explore new pathways and treatment
possibilities for not only RA but for all T cell dependent
inflammatory diseases.
Results
A spontaneous mutation in the SH3g11 gene protects against
autoimmune arthritis. The DA rat is commonly used in auto-
immunity research due to its high susceptibility to a number of
chronic inflammatory disorders such as arthritis and experi-
mental autoimmune encephalomyelitis11. We noticed an
increased variability in susceptibility to arthritis in our inbred DA
rat colony. Arthritis-resistant rats were selected and bred to
establish a new line (denoted DA mutated (DAMut)), which was
found to be completely protected against pristane-induced
arthritis (PIA; Fig. 1a, b). We suspected the underlying cause to
be of a genetic origin and not environmental. To test this
hypothesis, the DAMut colony was re-established by cesarean
sectioning into a SPF (FELASA II)- controlled facility. We
injected the rats with pristane and followed arthritis development.
The resulting clinical scores were similar to the conventional
facility ruling out obvious environmental factors (Supplementary
Fig. 1a, b). To genetically position the mutation, we crossed
DAMut rats to the genetically different, arthritis susceptible, E3.
DA-Pia457 rat strain12 and F2 offspring from this cross were
immunized to induce PIA. Subsequent linkage analysis disclosed
a significant association with arthritis incidence for a poly-
morphic marker on chromosome 9. Typing with additional
markers lead to the identification of a quantitative trait
locus (Pia43), at the telomeric end of chromosome 9 (Fig. 1c, d).
The Pia43 locus had not been identified in previous
E3xDA crosses13,14, confirming that this locus was unique to the
DAMut line. The fragment was introgressed into a congenic strain
DAMut.E3-Pia43 and minimized to 2Mb by new recombinations
(Fig. 1e, f).
To identify the specific genetic alteration, we sequenced the
DAMut rat genome and aligned it to the BN rat genome reference
(Rno5). All variants in the DAMut.E3-Pia43 congenic region were
manually compared to two previously sequenced DA
genomes15,16. No single nucleotide polymorphism (SNP) or
short insertion nor deletion (indel) was detected that could
distinguish DAMut from the other DA strains in the congenic
region, e.g., all 337 SNPs detected between DAMut and the
reference sequence were also found in the other DA genomes.
However, a structural variant was revealed, which was unique to
the DAMut rat, and appeared to be the result of an insertion of a
long terminal repeat (LTR) element of the ERV class I (ERV1) in
intron 1 of the SH3gl1 gene (Fig. 2a).
Retrotransposons such as LTR elements have been shown to
regulate gene expression in both mice and man17. To investigate
if this was also the case for the ERV1 insertion in the SH3gl1 gene
in DAMut rats, we determined the levels of lysine 4 methylation in
histone 3 (H3K4me3) and the acetylation of histone 4 (H4Ac)
using chromatin-immunoprecipitation (ChIP) and qPCR, as
these modifications have been associated with active gene
transcription18,19. We observed that H3K4me3 and H4ac levels
upstream of the inserted LTR were similar in DA and DAMut rats.
In contrast, levels in regions situated downstream of the insertion
were down-regulated (Fig. 2B, C), indicating that SH3gl1 gene
transcription was not active in DAMut rats. To determine if this
had any impact on gene expression we analysed peripheral blood
monocytic cells (PBMCs) from DA and DAMut rats and
quantified gene expression with qPCR. Strikingly, the DAMut
rats had almost no expression of the SH3gl1 gene compared to
DA rats (Fig. 2d). This vastly reduced gene expression also
translated to a reduced level of the SH3gl1 encoded protein EA2
as determined by western blotting (Fig. 2e). To confirm that the
arthritis resistance observed in the DAMut rats was due to a
deficiency in EA2 expression we introgressed a deletion of the
SH3gl1 gene into arthritis-susceptible B6N.Q mice through
backcrossing and evaluated them with collagen-induced arthritis
(CIA). Similar to the DAMut rats, the SH3gl1 deficient mice were
also protected from arthritis, in contrast to their SH3gl1 sufficient
wild-type littermates (Fig. 2f). To investigate whether the effect
was restricted to control only arthritis development or also other
autoimmune diseases, we tested experimental autoimmune
encephalomyelitis (EAE), a T-cell-dependent model of MS, which
confirmed the EA2 mediated protective effect seen in arthritis
(Fig. 2g). Additionally, we tested the T-cell independent collagen-
antibody induced arthritis model20 and observed no difference in
disease severity or induction (Fig. 2h, i). We conclude that EA2 is
a major regulator of T cell dependent autoimmune disease.
EA2 deficiency alters the induction threshold of autoreactive
T cells. Since EA2 deficiency had such a great impact on T cell
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20586-2
2 NATURE COMMUNICATIONS |          (2021) 12:610 | https://doi.org/10.1038/s41467-020-20586-2 | www.nature.com/naturecommunications
dependent autoimmune disorders we investigated if the expres-
sion of SH3gl1 increased in T cells after arthritis induction.
Indeed 8 days after in vivo activation the expression of SH3gl1
had more than doubled (Fig. 3a) suggesting an important func-
tion of SH3gl1 during T cell priming and activation. To further
elucidate if the protection in SH3gl1 deficient rats is mediated by
T cells we used the CD4+ αβ+ T cell dependent pristane-induced
adoptive transfer model21. Pristane-primed lymph node cells
from DA or DAMut rats were expanded for T cells ex vivo before
transfer into naïve DA recipients. Only cells from DA rat donors
induced severe arthritis (Fig. 3b), indicating that the DAMut rats
were not able to generate arthritogenic T cells. To confirm that
the arthritis resistance was intrinsic to T cells, we transferred
thymocytes from SH3gl1 deficient or wild-type littermate mice
into TCRβ knockout mice before the induction of glucose-6-
phosphate isomerase (GPI) induced arthritis. Mice receiving
Fig. 1 Arthritis regulating loci in the DAMut rat is restricted to a 2-Mb region on chromosome 9. a Mean arthritis score after pristane-induced arthritis in
5 DA and 7 DAMut rats. The arthritis data has been reproduced three times with the same results. b Incidence of arthritis after pristane-induced arthritis in
DA and DAMut rats. c LOD score plot for incidence of PIA in 51 (E3.DA-Pia457x DAMut) x DAMut rats of all genotyped chromosomes. d LOD score plot for
incidence of PIA in (E3.DA-Pia457 × DAMut) DAMut rats on chromosome 9, broken line at 2.63 indicate significant linkage e Schematic figure of the DAMut.
E3-Pia43 congenic fragment on chromosome 9 with location of the SH3gl1 gene. Microsatellite markers in the Acsbg2 and Uxs1 genes indicate inner border
of congenic fragment and markersMllt1 and Dazl indicate outer borders. f Mean arthritis score after pristane-induced arthritis in 8 DAMut and 4 DAMut E3-
Pia43 heterozygote littermates. Arthritis has been reproduced in several different congenic fragments with the same results. Non-parametrical
Mann–Whitney U test was used for statistical evaluation of data. Data are presented as mean with error bars indicating ± SEM with each dot representing
an individual value.
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SH3gl1 deficient thymocytes developed nearly no arthritis
(Fig. 3c) and had fewer antigen-specific cells compared to the
wild-type recipients as determined by an in vitro recall assay
using the GPI peptide while no significant difference could be
seen in mitogen activated cells (Fig. 3d). To determine if this
reduction in antigen-specific cells was due to a defect in the
thymic T cell development, we assessed thymic T cell populations
by flow cytometry. No difference in T cell populations could be
observed between the SH3gl1 deficient mice compared to their
wild-type littermates indicating that the reduced numbers of
Fig. 2 Endophilin A2 deficiency protects against autoimmunity in rodents. a Schematic picture of the SH3gl1 gene with the location of the inserted ERVI
long-term repeat element and location of the primer pairs used for quantification of the H3K4me3 and H4Ac levels. b Fold change of H3K4me3 levels in 3
DA and 3 DAMut naïve aged matched rats before (Primer pair 1 and 2) and after (Primer pair 3) the insertion in the SH3gl1 gene. c Fold change of H4Ac
levels in 3 DA and 3 DAMut naïve aged matched rats before (Primer pair 1 and 2) and after (Primer pair 3) the insertion in the SH3gl1 gene. d Fold change of
the SH3gl1 gene expression in PBMCs from 5 DA and 6 DAMut naïve aged matched rats. Relative fold change calculated to one DAMut reference sample.
e Western blot analysis of the expression of the Endophilin A2 protein in brain samples of three DA and DAMut rats. Histone 2B was used as loading
control. f Mean arthritis score after collagen-induced arthritis in 9 SH3gl1 knockouts and 16 wild-type littermates. Arthritis data has been reproduced twice
with the same results. g Mean EAE score after spinal cord homogenate induced EAE in 10 DA and 10 DAMut rats. h Incidence of collagen-antibody induced
arthritis in 10 SH3gl1−/− and 10 SH3gl1+/+ wild-type littermates. iMean arthritis score of sick mice from above experiment after collagen-antibody induced
arthritis in 4 SH3gl1 knockouts and three wild-type littermates. Non-parametrical Mann–Whitney U test was used for statistical evaluation of data. Data are
presented as mean with error bars indicating ±SEM with each dot representing an individual value.
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antigen-specific cells were not due to a defect in thymic T cell
development (Fig. 3e) but were instead induced in the periphery.
To better understand why the SH3gl1 deficient T cells do not
become arthritogenic we looked at activation markers and
induction of anergy. While no significant differences in activation
markers could be seen ten days after GPI-peptide immunization,
the SH3gl1 deficient T cells significantly upregulated anergy
markers like PD-1 and CD73/FR4 (Fig. 3f). In a subsequent
experiment comparing responses to GPI protein and ovalbumin,
the same trend was observed for GPI but not for the exogenous
antigen ovalbumin (Supplementary Fig. 2). We next investigated
if the SH3gl1 deficient T cells had a regulatory or suppressive
function in the pristane-induced T cell transfer model. Naïve DA
rats were given either pristane-primed DA cells alone or together
with an equal number of DAMut cells, with DAMut cells alone
serving as a negative control. No reduction in arthritis severity
was evident in recipients receiving pristane- primed DA cells
together with DAMut cells, indicating that DAMut T cells do not
exert their regulatory function via active suppression (Fig. 3g, h)
but rather via inhibited activation.
EA2 deficient rodents develop normally and mount a normal
response to cancer and infection. EA2 is a ubiquitous protein
with high expression in the central nervous system22. Thus, EA2
deficiency could potentially affect many cell types and impact
development. However, we did not observe any major physiolo-
gical disturbances caused by EA2 deficiency in DAMut rats by
general measurements such as blood cell counts, body weight,
breeding capacity and life span (up to 1.5 years) in which the
DAMut rats were identical to their normal DA littermates (Sup-
plementary Fig. 3a–e). Similarly to the DAMut rats, the SH3gl1
deficient mice develop normally as compared to their wild-type
littermates8. Given that the EA2 deficient rodents exhibited a
profound protection against autoimmune diseases, we assumed
that they could have a severely defective immune system. Our
animal facility is specific pathogen free but had an outbreak of S.
aureus caused infections which provoked septic arthritis in
immunodeficient mice23. However, no SH3gl1 deficient animals
developed a clinical S. aureus infection during this outbreak. To
further challenge the SH3gl1 deficient mice towards bacterial
infections, an arthritogenic S. aureus LS-1 strain24 was inoculated
intravenously. This septic arthritis model using S. aureus LS-1
strain has been shown to be dependent on T cells via activation of
T cells by the superantigen, toxic shock syndrome toxin-1 (TSST-
1)25. In this model of septic arthritis, we did not observe any
difference in bacterial clearance or development of arthritis in
SH3gl1 deficient mice compared to wild-type littermates (Sup-
plementary Fig. 3f, g). To further challenge the immune system in
EA2 deficient mice, we injected SH3gl1 deficient and wild-type
littermate mice with B16F10 melanoma cells and followed tumor
growth. No excessive tumor growth was observed in EA2 defi-
cient mice compared to wild-type littermates (Supplementary
Fig. 3h). Thus, EA2 deficiency seems to affect regulation of
autoimmunity but does not affect the general health of the
rodents nor their susceptibility to a bacterial infection caused by
S. aureus nor an excess growth of cancer cells.
Fig. 3 T cells regulate Endophilin A2 mediated protection against arthritis. a Expression of SH3gl1 in sorted T cells from lymph nodes from DA rats at Day
0 and Day 8 after pristane immunization. b Mean arthritis score after adoptive transfer of pristane-primed DA and DAMut cells to 9 respectively 4 naïve
DA recipients. The adoptive transfer experiment has been reproduced a total of three times with the same results. c Mean arthritis score after GPI-induced
arthritis in 17 and 19 TCRβ knockout recipients that had received either SH3gl1−/− or SH3gl1+/+ thymocytes respectively, 7 days prior to disease induction.
Data is pooled from three individual experiments. d Number of antigen specific IL-2, IL-17A and IFNg producing T cells after recall stimulation with GPI
peptide and IL-2 producing cells after ConA stimulation day 44 after GPI-induced arthritis. Data from 9 TCRβ knockout mice reconstituted with wild-type
T cells and 8 TCRβ knockout mice reconstituted SH3gl1 T cells. Recall experiment has been repeated twice in SH3gl1−/− mice. e Frequency of double
negative (DN), double positive (DP), single positive CD4 (SP CD4), and single positive CD8 (SP CD8) thymocytes in 8 SH3gl1−/− and 8 SH3gl1+/+ mice.
Data has been reproduced twice. f Frequency of CD25, CD44, PD-1, CD73+FR4+, Ki-67, and FoxP3 positive cells in CD4+TCRb+ cells from inguinal lymph
nodes ten days after GPI-peptide immunization from 6 SH3gl1−/− and 6 SH3gl1+/+ mice. g Mean arthritis score in naïve DA recipients after adoptive
transfer of pristane-primed DAMut cells only, DA cells only or DA cells in addition with DAMut cells, 7 rats per group. h Arthritis sum score of the DA
recipients above after adoptive transfer of pristane-primed DA cells only or addition with DAMut cells, 7 rats per group. Non-parametrical Mann–Whitney U
test was used for statistical evaluation of data. Data are presented as mean with error bars indicating ±SEM with each dot representing an individual value.
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EA2 deficiency leads to reduced T cell activation via the TCR.
Considering the endocytic function of EA2 and the profound
effect that loss of EA2 expression had on T cells specifically, we
reasoned that EA2 might be important for the internalization of
the TCR. Thus, we checked whether EA2 co-localized with the
TCR upon activation using a proximity-ligase assay. While no co-
localization could be found in un-stimulated cells, we could see
that EA2 and the TCR co-localized after only three minutes of
anti-CD3/CD28 stimulation (Fig. 4a and Supplementary Fig. 4).
We next studied the kinetics of the TCR internalization and
indeed, SH3gl1 deficient T cells internalized their TCRs at a
slower rate compared to SH3gl1 sufficient T cells (Fig. 4b) with a
reduced internalization seen already at 15 min after stimulation.
The observed decreased rate of TCR internalization was not due
to an increased recycling of TCR as differences in TCR inter-
nalization between the SH3gl1 deficient and sufficient T cells
sustain even after Brefeldin A treatment (Fig. 4c). To investigate if
this had any impact on the responsiveness of the T cells we
investigated downstream TCR signaling molecules in SH3gl1
deficient and wild-type T cells. A reduced TCR signaling cascade
was observed in SH3gl1 deficient T cells compared to wild-type
T cells, with reduced levels of phosphorylated Zap70 and acti-
vation of ERK1/2 (Fig. 4d–f). This reduction in responsiveness in
the SH3gl1 deficient T cells translated to reduced T cell pro-
liferation following in vitro stimulation via CD3/CD28 (Fig. 4g,
h). The observed reduced proliferation was not the result of
reduced internalization of the IL-2 receptor as previously
described26 but must stem from a reduced activation via the TCR
(Supplementary Fig. 5).
SH3GL1 regulates TCR responses in human T cells and its
expression is upregulated in RA patients. Since EA2 is highly
conserved and had such a profound effect on T-cell-mediated
arthritogenicity in both mice and rats, we next investigated to
what extent SH3GL1 is of importance in human T cells. To
demonstrate the relevance of EA2 in human T cells we made
SH3GL1 CRISPR knock-out Jurkat T cells (Supplementary Fig. 6)
and stimulated them in vitro with anti-CD3/CD28. Both TCR
signaling and TCR internalization were reduced in SH3GL1
deficient Jurkat cells compared to wild-type control and normal
Jurkat T cells (Fig. 5a, b). We addressed the possibility that
SH3GL1 could be overexpressed in T cells from RA patients and
determined the expression of both SH3GL1 and the TCR mole-
cule CD3e from whole blood of RA patients and healthy controls
and found that the SH3GL1 expression correlated with expression
of the CD3E molecule (Fig. 5c). Similar to the findings in animal
models, the levels of SH3GL1 was higher in RA patients when
normalized for CD3E (Fig. 5d) corroborating the data from the
NCBI GEO database27 where SH3gl1 gene expression was found
to be upregulated in sorted CD4+ T cells from RA patients
compared to healthy control (Fig. 5e). Thus, SH3GL1 has a
conserved mechanistic function in T cells across species and is
relevant in a human disease setting.
Discussion
Aberrant activation of autoreactive T cells is the key for the self-
perpetuating vicious circle of activation of both the innate and
adaptive immune response that leads to chronicity and lack of
resolution in autoimmune diseases. Using a rat animal model of
RA, we discovered SH3GL1 as a major regulator of T cell effector
function and autoimmune diseases. We show that deficiency of
SH3gl1 leads to a complete protection against autoimmune dis-
eases in both mutated DA rats and in SH3gl1 knockout mice
and that this results from loss of T cell effector functions.
Fig. 4 Endophilin A2 co-localizes with the TCR upon activation and regulates TCR internalization and signaling. a EA2 co-localization with the
TCR in Jurkat cells after anti-CD3/CD28 stimulation determined by proximity-ligase assay and visualized as TexasRed+ spots using confocal imaging.
b Percentage of internalized TCR in T cells from 5 DA and 5 DAMut rats after anti-CD3/CD28 stimulation. Data has been reproduced two times.
c Percentage of internalized TCR in CD4+CD3+ T cells from three SH3gl1−/− and SH3gl1+/+ mice stimulated with anti-CD3/CD28 for 30min in the
presence or absence of Brefeldin A at 1.25 μg/ml. Experiment has been repeated twice with the same results. d Representative Western blot analysis from
two experiments of phosphorylated and unphosphorylated ZAP70 and ERK1/2 in T cells from two SH3gl1−/− and SH3gl1+/+ mice stimulated with anti-
CD3/CD28 for 0, 3, and 7min. Histone 2B was used as loading control. e Normalized OD values of phosphorylated Zap70 compared to unphosphorylated
Zap70 from two SH3gl1−/− and SH3gl1+/+ mice. f Normalized OD values of phosphorylated ERK1/2 compared to unphosphorylated ERK1/2 from two
SH3gl1−/− and SH3gl1+/+ mice. g Flow cytometry blot showing in vitro cell proliferation of DAMut and DA T cells 72 h after anti-CD3/CD28 stimulation.
h Division index of sorted T cells from 7 DA and 5 DAMut rats after 72 h of anti-CD3/CD28 stimulation. Non-parametrical Mann–Whitney U test was used
for statistical evaluation of data. Data are presented as mean with error bars indicating ± SEM with each dot representing an individual value.
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Furthermore, we show that SH3gl1 expression was increased in
T cells during autoimmune arthritis in both rodents and RA
patients.
TCR internalization and surface recycling following peptide-
MHC recognition on the antigen presenting cell plays a pivotal
role in establishing a stable immunological synapse and sub-
sequent T cell activation28. To limit potential induction of
autoreactive responses, T cell activation is tightly regulated via the
TCR and co-stimulatory molecules. Both the surface expression
of the TCR as well as the adapters in the TCR signaling cascade
are of importance in dictating the effector functions of the T cells.
For example, CD4+ T cells deficient in the WASH protein show
reduced trafficking of the TCR and proliferation of T cells. Similar
to SH3gl1 deficient animals, CD4+ conditional WASH knockout
mice are also protected from EAE29. Several earlier studies
demonstrate that SH3GL1 is necessary for internalization and
trafficking of a number of receptors26,30,31. Our data demonstrate
that SH3GL1 also regulates the internalization of the TCR.
Because of the importance of TCR internalization and formation
of the immunological synapse for efficient TCR signaling, a lack
of SH3GL1 leads to reduced T cell signaling and would subse-
quently result in reduced numbers of autoreactive T cells, in turn
limiting the arthritis development. The importance of adapters in
the TCR signaling cascade was recently demonstrated by target-
ing the adapter protein NCK32. Like in SH3gl1 deficient animals,
inhibition of NCK reduce proliferation of the T cells and leads to
induction of immunosuppression and protection against EAE.
Although the regulation of the TCR is different between SH3GL1
and NCK the resulting outcome seems to be similar. Develop-
ment of effective tissue restricted immunotherapies in the field of
autoimmune diseases has proven difficult, with a variety of
antigen-specific vaccination strategies developed in the 1990s
with limited success33,34. Consequently, instead of attempting to
address antigen specificity, the field moved more into the deple-
tion of molecules (e.g. TNF blockade35) or whole cell populations
(e.g. B cells using anti-CD20 antibody36) involved in the patho-
genesis. Although these therapies have been beneficial they are
not curative and there is still a substantial number of patients who
are non-responders or develop severe side-effects such as
increased susceptibility to infections37,38. Our results with SH3gl1
in rodents demonstrate an interesting pathway by which activa-
tion of autoreactive T cells is modulated via the TCR while
retaining the ability to respond to pathogens. Thus, SH3GL1
targeting could be a promising therapeutic treatment strategy for
RA as well as in other T cell-mediated diseases.
Methods
Animals. The E3/ZtmRhd and DA/ZtmRhd rats originated from the Zentralin-
stitute für Versuchstierzucht, Hannover, Germany and were bred for more than 20
brother/sister mating generations in the animal facility of Medical Inflammation
Research lab. The DAMut rats were isolated from the DA/ZtmRhd stock and bred
for more than 10 brother/sister mating generations. To obtain the (E3.DA-Pia457x
DAMut) DAMut rats used in the linkage analysis, 2 male DAMut rats were bred with
4 female E3.DA-Pia45712 rats. Subsequently, 10 female F1 hybrids were bred with 6
DAMut male rats to produce 51 males of the F2 offspring. The C57BL/6.129-
Sh3gl1tm1Pdc/J8, titled SH3gl1−/− in paper, mice were a kind gift from Professor
Pietro de Camilli and backcrossed for five generations to the arthritis susceptible
C57BL/6 mouse, expressing MHC class II A(q)39. C57BL/6.129P2-Tcrbtm1Mom/J
(Stock No: 002118), titled TCRb−/− in paper, mice were bought from Jackson
Laboratory and backcrossed to C57BL/10 expressing the MHC class II A(q) for
more than ten generations. All animals included in the experiments were kept in a
specific pathogen-free environment following the Federation of European Animal
Laboratory Science Association guidelines (FELASA II), in a climate-controlled
Fig. 5 EA2 has a conserved function in human T cells and is upregulated in RA patients. a TCR internalization in SH3GL1 CRISPR knockout Jurkat cells
(T3-5 and T3-21) and wild-type control (T3-23). b Representative western blot analysis from two experiments of phosphorylated ZAP70 and ERK1/2 in
T cells from in SH3GL1 CRISPR knockout (T3-5 and T3-21), wild-type control (T3-23), and Jurkat (J) cells with anti-CD3/CD28 for 0, 3, and 7min. Histone
2B was used as loading control. c Correlation of CD3e and SH3GL1 gene expression in whole blood of healthy controls and RA patients. Each circle
represents one individual. d Normalized SH3GL1 gene expression to CD3e gene expression in whole blood of 35 healthy controls and 36 RA patients,
randomly selected from the cohort used in c. Each circle represents one individual. e SH3GL1 gene expression in sorted CD4+ T cells from 10 healthy
controls and 8 RA patients (data accessible at NCBI GEO database, accession GSE4588). Non-parametrical Mann–Whitney U test was used for statistical
evaluation of data. Data are presented as mean with error bars indicating ±SEM with each dot representing an individual value.
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environment with a 12-h light/dark cycle and fed standard rodent chow and water
ad libitum. All animal experiments followed the ARRIVE guidelines, they were
performed blindly, age- and sex balanced, mixed in cages and with littermate
controls, and approved by the local ethical committees (Malmö/Lund, Göteborg
and Stockholm, Sweden, ethical permits M109/07, M107/07, N67/10, N69/10,
N169/10, N490/12, N134/13, 353-2012, N35/16, and N288/15).
Patients and healthy controls. Whole blood from RA patients and healthy
controls matched for gender, age and ethnicity were collected in PAX tubes at the
Rheumatology Clinic at Karolinska University hospital. RA patients all met the
1987 American college of rheumatology criteria for diagnosing RA. Informed
consent was obtained from all the participants and the Stockholm ethical review
board approved the study.
Experimentally induced arthritis. Pristane-induced arthritis (PIA) was induced
by a single injection of 100 μl pristane (2, 6, 10, 14-tetramethylpentadecane;
ACROS Organics) at the base of the tail. Collagen-induced arthritis (CIA) was
induced by injection of 100 μg of pepsin-digested rat collagen type II (as described
in40) emulsified in 100 μl complete Freund’s adjuvant (Difco) with a boost injection
at day 35 with collagen type 2 in incomplete Freund’s adjuvant (Difco). Glucose-6-
phosphate isomerase (GPI)-induced arthritis was induced by a single injection of
synthetically produced peptide corresponding to the human GPI protein aa325-339
(hGPI325-339) emulsified in complete Freund’s adjuvant (Difco)41. S. aureus-
induced arthritis was induced by inoculation of the S. aureus TSST-1-producing;
LS-1 strain intravenously in one of the tail veins with 2.07 × 107 S. aureus LS-1/ml
in a total volume of 200 μl phosphate-buffered saline (PBS). Arthritis development
in PIA, CIA, and GPI experiments were monitored using a macroscopic scoring
system. Each limb with the highest possible count of 15, thus with a total possible
score of 60 per animal described in more detail for rats in42 and for mice in43. The
S. aureus-induced arthritis development was monitored using a macroscopic
scoring system where each limb was scored according to a scoring scheme (0,
neither swelling nor erythema; 1, mild swelling and/or erythema; 2, moderate
swelling and erythema; and 3, marked swelling and erythema). The total score was
calculated by adding up all the scores within each animal tested.
Experimental autoimmune encephalomyelitis. Spinal cord from naïve DA rats
was taken and homogenized. EAE was induced by a single injection of spinal cord
homogenate emulsified in incomplete Freund’s adjuvant (Difco). EAE was mac-
roscopically scored according to the following scoring scheme 0=Normal, 1= Tail
weakness, 2= Tail paralysis, normal gait, 2.5= Tail paralysis, little affected gait, 3
= Tail paralysis, low back and mild waddle, 3 .5= Tail paralysis and low back,
severe waddle, 4= Tail paralysis, severe waddle, less sure footing, 4.5= Tail
paralysis, severe waddle, falling and lost balance, 5= Tail paralysis and paralysis of
one limb, crawling, 6= Tail paralysis and paralysis of a pair of limbs, back is
affected, 7= Tetraparesis, and 8= Pre-morbid or deceased.
Adoptive T cell transfer of arthritogenic cells. Eight days after pristane injection,
rats were euthanized by CO2 inhalation and inguinal lymph nodes were taken and
mechanically homogenized through 40μm filters. Cells were washed in PBS and
T cells reactivated and expanded in vitro in D-MEM supplemented with HEPES
(GIBCO), streptomycin/D-penicillin (104 IU/ml penicillin, 10 mg/ml streptomy-
cin; Invitrogen Life Technologies), β-mercaptoethanol (GIBCO), 5% fetal calf
serum (GIBCO) and Concavalin A (3 µg/ml; Sigma-Aldrich). Cells were incubated
at 37 °C and 5% CO2 for 48 h. Cells were washed in PBS and transferred to naïve
DA rats.
Genotyping and linkage analysis. Toe biopsies were sampled and DNA was
prepared by alkaline lysis. The DNA was amplified using fluorescence-marked
microsatellites and standard polymerase chain reaction (PCR) reagents (dNTPs,
MgCl2, Taq Polymerase). The solution was assayed in a PCR Thermal Cycler and
the final PCR products were pooled and size-fractioned on a MegaBACE 1000
(Amersham Pharmacia Biotech, Uppsala, Sweden) alternatively on a ABI3730
DNA Analyzer (Applied Biosystems, Life Technologies Corporation, Carlsbad,
USA). The data was analyzed using the enclosed program Genetic Profiler 1.1
respectively GeneMapper® Software v4.1 Sequences for microsatellite markers used
in the linkage analysis were retrieved from Rat Genome Database (http://rgd.mcw.
edu/rgdweb/search/markers.html?100). Additional primers used in mapping the
congenic fragments were created using genomic sequences from publicly available
rat sequences at NCBI Gene (http://www.ncbi.nlm.nih.gov/gene). Microsattellites
were identified and primers were created using the primer design program, Pri-
mer3 (http://biotools.umassmed.edu/bioapps/primer3_www.cgi). Primer specificity
was controlled by running the sequences through Primer-BLAST at NCBI. (http://
www.ncbi.nlm.nih.gov/tools/primer-blast/). Oligos were later ordered from Euro-
fins MWG Operon. Linkage analysis was performed using R (The R Foundation of
Statistical Computing, version 2.0.1) and R/qtl44. The normal model and Haley-
Knott regression method (1-cM steps) were used for all calculations. Significance
threshold of logarithm of the odds (LOD) was determined using permutation tests
(n= 10000), in which p < 0.05 was considered significant. The genetic map was
generated in the R/qtl environment based on the recombinations in the cross.
Chromatin-immunoprecipitation and quantitative PCR. Based on previous
ChIP-Seq results from BN and SHR rats45, we identified regions with high levels of
H3K4me3 modifications in close proximity to the Sh3gl1 gene. Spleen powder
(100 mg) from 3 DA and 3 DAMut rats were used for nuclei isolation and sub-
sequent ChIP analysis was performed according to45. The regions of interest were
analyzed by ChIP followed by qPCR on ABI 7900HT detection system (Applied
Biosystems). PCR primers were designed to amplify designated genomic regions
using Primer Express software (Applied Biosystems). qPCR assays were carried out
in 384-well plates with a final volume of 20 µL each for 40 cycles. We used Power
SYBR Green PCR Master Mix (Applied Biosystems) with diluted ChIPed DNA or
un-enriched input DNA as template. Enrichment ratios were calculated according
to the 2-ΔΔCt method with endogenous controls (Gapdh) similar to gene
expression data sets. For H3K4me3 and H4ac modification see supplementary
Table 1 for sequences of primers used for quantification
RNA extraction and quantitative- polymerase chain reaction. Mononuclear
leukocytes from blood (separated from Ficoll-density gradient) or sorted T cells
(Pan T Cell MicroBeads, Miltenyi Biotec) were obtained from naïve DA and
DAMut rats and RNA was isolated (Trizol and Pure-link mRNA kit, Invitrogen).
Whole blood from RA patients and healthy controls were collected in PAXgene
Blood RNA Tubes and total RNA was extracted with the PAXgene Blood RNA kit
(PreAnalytiX, Feldbachstrasse, Switzerland) according to the manufacturer’s pro-
tocol. cDNA conversion was performed with an iScript cDNA synthesis (Bio-Rad,
Hercules, CA, USA). Gene expression experiments were performed using TaqMan
gene expression assays(Hs04235263_g1(Sh3gl1), Hs04194521_s1 (PPIA),
Hs01062241_m1(CD3e), Rn01527769_g1(Sh3gl1), Rn01527840_m1(Hprt1),
Applied Biosystems) and samples were run on a CFX96 RT-PCR(Bio-Rad)
according to manufacturers description. Relative fold change was calculated
according to the 2-ΔΔCt method after normalization to reference gene, Hprt1 for
rat gene expression and PPIA for the human gene expression experiments.
Western blotting. Whole cell lysates from DA and DAMut rats were obtained from
brain samples by lysis in RIPA buffer (ThermoScientific). Samples were run in a
NuPAGE 4–12% Bis-Tris gel (Novex, Invitrogen) and transferred to a PVDF
membrane (EMD, Millipore). Blots were blocked with 5% bovine serum albumin
(Sigma-Aldrich) in Tris-buffered saline with 0.1% Tween 20 (Cell Signaling
Technology) and subsequently incubated with mouse anti-rat Endophilin A2
(clone S51-1, Origene Technologies, Inc) and rabbit anti-histone 2B (Cat. No
C49810, LifeSpan Biosciences, Inc). Blot was incubated with peroxidase-conjugated
goat anti-mouse IgG(Cat no. 115-035-062, Jackson ImmunoResearch laboratories
Inc.) or peroxidase-conjugated donkey anti-rabbit IgG (Cat no.771-036-152,
Jackson ImmunoResearch laboratories Inc.) respectively and developed using
enhanced chemiluminescence. Pictures including the entire blot can be found in
the Source Data file.
Determining number of antigen-specific cells with enzyme-linked immuno-
spot (ELISpot) assay. Single cell suspension from spleens of mice previously
immunized for GPI arthritis was added to plates (MSIPS4W10, Millipore) pre-
viously coated with antibodies to IL-2 (clone JES6-IA12), IL-17(clone TC11-
18H10) and a-IFNg(AN18) and stimulated for 48 h with 10 μM hGPI325-339 in D-
MEM supplemented with HEPES (GIBCO), streptomycin/D-penicillin (104 IU/ml
penicillin, 10 mg/ml streptomycin; Invitrogen Life Technologies), b-
mercaptoethanol (GIBCO), 10% fetal calf serum (GIBCO). Plates were washed and
incubated with biotinylated antibodies to IL-2 (clone 5H4), IL-17 (clone TC11-
8H4) and IFNγ (R46A2). Plates were washed and Extravidin-Phosphatase (Sigma)
was added to wells and incubated for 45 min and washed. Plates were subsequently
developed using BCIP/NBT(Sigma). Plates were scanned, analyzed and number of
reactive cells were counted with ImmunoSpot software (Cellular Technology Ltd.).
T cell development. Single cell suspension from thymus of C57BL/6.129-
Sh3gl1tm1Pdc/J.Q and their wild-type littermates were stained with anti-mouse
monoclonal antibodies (B220-Fitc, CD5-PE, CD25-PECy7, TCRb-PerCP5.5, CD4-
Q605, CD8-BV650, CD69-APC, CD44-A750) for 20 min at 4 °C. After washing
with PBS, cells were acquired on a LSRII (BD Biosciences, Franklin Lakes, NJ,
USA) using the BD FACSDiva™ software (BD Biosciences) with gates set to include
all viable cells and later analyzed by FlowJo (Tree Star, Inc.) software.
Cell proliferation assays. T cells from DA and DAMut lymph nodes were nega-
tively sorted using biotinylated mouse anti-rat CD11b/c (Clone OX42, Biolegend)
and mouse anti-rat CD45Ra (Clone OX33, Biolegend) and anti-biotin MicroBeads
(Miltenyi Biotec). Sorted T cells were then labeled with CellTrace-Violet (Mole-
cular Probes, Invitrogen) and added to plates coated with anti-rat αβTCR(Clone
R73) and anti-rat CD28(Clone JJI319) in D-MEM supplemented with HEPES
(GIBCO), streptomycin/D-penicillin (104 IU/ml penicillin, 10 mg/ml streptomy-
cin; Invitrogen Life Technologies), b-mercaptoethanol (GIBCO), 10% fetal calf
serum (GIBCO) and incubated at 37 °C, 5% CO2. After 72 h cells were washed and
later acquired on a LSRII (BD Biosciences, Franklin Lakes, NJ, USA) using the BD
FACSDiva™ software (BD Biosciences) with gates set to include all viable cells and
later analyzed by FlowJo (Tree Star, Inc.) software.
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TCR internalization assay. Lymph node cells from DA and DAMut rats were
stained with mouse anti-rat CD3 (Clone 1F4) conjugated with Fitc (Biolegend) at 4
°C. Labeled cells were added to plates coated with anti-rat αβTCR (Clone R73) and
anti-rat CD28(Clone JJI319) in D-MEM supplemented with HEPES (GIBCO),
streptomycin/D-penicillin (104 IU/ml penicillin, 10 mg/ml streptomycin; Invitro-
gen Life Technologies), b-mercaptoethanol (GIBCO), 10% fetal calf serum
(GIBCO), and incubated for 15, 30, and 60 min at 37 °C or left on ice for zero time
point. Cells were washed and spilt into two fractions, were one fraction was
stripped of surface anti-CD3-Alexa488 antibodies with PBS (GIBCO) pH 2 for 1
min and the other fraction left untreated. For the TCR internalization assay with
the CRISPR Jurkat T cells the cells were stained with anti-human CD3 (Clone
UTCH1) conjugated with Alexa488 (BD Biosciences) at 4 °C. Labeled cells were
added to plates coated with anti-human CD3 (Clone Hit3a, BD Biosciences) and
anti-human CD28(Clone CD28.2, BD Biosciences) in RPMI1640 (GIBCO), sup-
plemented streptomycin/D-penicillin (104 IU/ml penicillin, 10 mg/ml streptomy-
cin; Invitrogen Life Technologies) and 10% fetal calf serum (GIBCO) and
incubated for 15, 30, and 60 min at 37 °C or left on ice for zero time point. Cells
were washed and spilt into two fractions, were one fraction was quenched of
surface anti-CD3-Alexa488 signal with unlabeled anti-Alexa488 (MolecularProbes,
Invitrogen) and the other fraction left untreated. For the Brefeldin A inhibitor
experiment lymph node cells from SH3gl1−/− and SH3gl1+/+ mice were stained
with Armenian hamster anti-mouse TCRb (Clone H57-597, Biolegend) conjugated
with Alexa488 at 4 °C. Labeled cells were added to plates coated with anti-mouse
CD3e (Clone 145-2C11, BD Biosciences) and anti-mouse CD28(Clone 37.51, BD
Biosciences) in D-MEM supplemented with HEPES (GIBCO), streptomycin/D-
penicillin (104 IU/ml penicillin, 10 mg/ml streptomycin; Invitrogen Life Technol-
ogies), b-mercaptoethanol (GIBCO), 10% fetal calf serum (GIBCO) and together
with 1, 25ug/ml Brefeldin A (Sigma) and incubated for 30 min at 37 °C or left on
ice for zero time point. Cells were washed and spilt into two fractions, quenched or
no quench, and subsequently stained with rat anti-mouse CD45R-PE-Cy7 (Clone
RA3-6B2, BD Biosciences), rat anti-mouse CD4-BV605 (Clone RM4.5, BD Bios-
ciences), rat anti-mouse CD3-PacificBlue (Clone 17A2, Biolegend) and anti-
Alexa488 (MolecularProbes, Invitrogen) to half of the samples (quenched). Cells
were acquired on a LSRII (BD Biosciences, Franklin Lakes, NJ, USA) using the BD
FACSDiva™ software (BD Biosciences) with gates set to exclude doublets and
include all viable cells determined as LIVE/DEAD™ -Near-IR (Invitrogen) negative
cells and later analyzed by FlowJo (Tree Star, Inc.) software. Percentage of inter-
nalized CD3-Alexa488 was calculated as (Qx-Q0)/(Tt-Q0)x100, where Qx is the
mean fluorescence of cells quenched with anti-Alexa488 at each time point, Q0 is
the mean fluorescence of cells quenched at time zero, and Tt is the mean fluor-
escence of cells that were not quenched.
TCR signaling. T cells from lymph nodes and spleens of C57BL/6.129-
Sh3gl1tm1Pdc/J.Q mice and their wild-type littermates were sorted (Untouched
CD4+ T cells MicroBeads, Miltenyi Biotec) and resuspended in D-MEM supple-
mented with HEPES (GIBCO), streptomycin/D-penicillin (104 IU/ml penicillin,
10 mg/ml streptomycin; Invitrogen Life Technologies), b-mercaptoethanol
(GIBCO), 10% fetal calf serum (GIBCO). Cells were rested for one hour at 37 °C
and later added to plates coated with 10 μg/ml rat anti-mouse CD3(Clone 145-
2C11, BD Biosciences) and 5 μg/ml rat anti-mouse CD28(Clone 37.51, BD Bios-
ciences) and stimulated for 3 and 7 min. Cells were lysed using M-PER(Thermo-
Scientific) supplemented with HALT phosphatase and protease inhibitors
(ThermoScientific). Samples were run on a NuPAGE 4-12% Bis-Tris gel (Novex,
Invitrogen) and transferred to PVDF membrane (EMD, Millipore). Blots were
blocked with 5% bovine serum albumin (Sigma-Aldrich) in Tris-buffered saline
with 0.1% Tween (Cell Signaling Technology) and subsequently incubated with
rabbit anti- mouse phosphorylated Zap70 (Clone 65E4, Cell Signaling Technology),
rabbit anti- phosphorylated-p44/42 MAPK (Erk1/2; Thr202/Tyr204; Cell Signaling
Technology) and rabbit anti-histone 2B (Cat no. ab1790 Abcam) as loading con-
trol. Blot was incubated with peroxidase-conjugated donkey anti-rabbit IgG (Cat
no.771-036-152, Jackson ImmunoResearch laboratories Inc.) and developed using
enhanced chemiluminescence. Pictures including the entire blot can be found in
the Source Data file.
Whole genome sequencing and bioinformatics analysis. Genomic DNA from
liver from DAMut rats was isolated using the nuclear lysis buffer, followed by
ethanol precipitation of the DNA. DNA integrity was validated with gel electro-
phoresis. Next generation sequencing was performed at Science for Life laboratory,
Stockholm, Sweden using Illumina HiSeq 2000 with 650 bp insert standard DNA
(Illumina TruSeq DNA) and paired-end sequencing (2x 100 bp). Sequences were
aligned to the BN reference sequence Rno5 and compared to previous sequenced
DA genomes15,16. Visual inspection of DAMut sequence alignments in Integrative
Genomics Viewer (IGV), Broad Institute, revealed a region of partial or improperly
paired alignments in intron 1 of the Sh3gl1 gene and indicated an insertion. The
reads aligned in the region and their paired sequences were assembled using Tri-
nity46. The inserted sequence was identified as an LTR/ERV1 element, using
RepeatMasker (http://www.repeatmasker.org/cgi-bin/WEBRepeatMasker) predic-
tion of the assembled sequences. The insertion was confirmed by Sanger
sequencing.
Colony-forming units in kidneys of S. aureus injected mice. Kidneys were
aseptically dissected, kept on ice, homogenized, serially diluted in PBS and spread
on blood agar plates. After incubation for 24 h at 37 °C, the number of colony-
forming units (CFU) per kidney pair was determined.
Tumor model. B16F10 melanoma cells were obtained from ATCC and cultured in
5% CO2 at 37 °C using 10% deactivated FBS in high glucose DMEM media sup-
plemented with 4.5 grams/ml of glucose, 1 mM pyruvate, 1.5 g of NaHCO3/ 500 ml
(Gibo GlutaMAX™, Thermofisher). Cells were washed two times with 37 °C PBS,
trypsined with 1X EDTA trypsin, then neutralized with 1:1 ratio of 10% FBS
DMEM growth medium to trypsin and 200 µl/mouse of serum free cell growth
medium containing 1 × 106 B16F10 (passage 10) p10 melanoma cells were injected
subcutaneously. Tumor volume was assessed using an electronic caliper and caliper
formula (Length ×Width2 × 0.52), where the width was the smallest dimension.
Maximum allowed tumor size is 1.5cm2 as calculated by (Length ×Width2 × 0.52).
Generation of Clustered regularly interspaced short palindromic repeats
(CRISPR)/Cas9 – SH3GL1 knock-out Jurkat cells. SH3GL1 CRISPR knock-out
cells were generated and bought from GenScript Ltd. Two clones T3-5 and T3-21
were predicted to be SH3GL1 knock-outs and T3-23 to be wild type. The three
clones were confirmed to be either SH3GL1 knock-out or wild-type Jurkat cells by
and quantitative- polymerase chain reaction and western blotting (Supplementary
Fig. 4a, b).
Proximity- ligase assay. Co-localization of EA2 and TCR was analysed by
proximity ligation assay using the Duolink® PLA Starter Kit Mouse/Rabbit from
Sigma (Cat. No DUO9210) according to the manufacturer’s description. EA2
was detected using primary rabbit anti-human EA2 (Sigma HPA021485) at 1ug/ml.
TCR was detected using primary mouse anti-human CD3 (BD Biosciences
Clone Hit3a) at 1ug/ml. Primary antibodies were detected using Duolink® In Situ
PLA® Probe Anti-Rabbit PLUS, Affinity purified Donkey anti-Rabbit IgG (H+ L)
and Duolink® In Situ PLA® Probe Anti-Mouse MINUS, Affinity purified
Donkey anti-Mouse IgG (H+ L) provided by the kit according to manufacturer’s
recommendations. Nuclei were stained using DAPI at 0.5ug/ml for 20 min in
PBS. Cells were imaged on a Zeiss LSM 800 confocal laser scanning microscope
(Zeiss). TexasRed was detected at λex594nm/λem624nm and DAPI at 358 nm/
λem461nm. For image analysis, events were counted using the Analyze Particles
function on ImageJ 1.52i. The number of TexasRed positive spots were related to
the number of DAPI positive events to give a ratio of TexasRed positive events
per cell.
Statistical analysis. Visualization and calculations of arthritis and EAE data and
immunoassays was done using GraphPad Prism v5 software program. The non-
parametrical Mann–Whitney U test was used for statistical evaluation of arthritis
scoring data and immunoassay. P-values < 0.05 were considered significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data that support the findings of this study are available in the supplemented data
source file and from the corresponding authors. Source data are provided with this paper.
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